Skip to content

Research at St Andrews

Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

Research output: Contribution to journalArticle

Abstract

Gemcitabine is a fluoropyrimidine analogue that is used as a mainstay of chemotherapy treatment for pancreatic and ovarian cancers, amongst others. Despite its widespread use, gemcitabine achieves responses in less than 10% of patients with metastatic pancreatic cancer and has a very limited impact on overall survival due to intrinsic and acquired resistance. NUC-1031 (Acelarin), a phosphoramidate transformation of gemcitabine, was the first anti-cancer ProTide to enter the clinic. We find it displays important in vitro cytotoxicity differences to gemcitabine, and a genome-wide CRISPR/Cas9 genetic screening approach identified only the pyrimidine metabolism pathway as modifying cancer cell sensitivity to NUC-1031. Low deoxycytidine kinase expression in tumour biopsies from patients treated with gemcitabine, assessed by immunostaining and image analysis, correlates with a poor prognosis, but there is no such correlation in tumour biopsies from a Phase I cohort treated with NUC-1031.
Close

Details

Original languageEnglish
Article number7643
Number of pages13
JournalScientific Reports
Volume9
DOIs
Publication statusPublished - 21 May 2019

    Research areas

  • Gemcitabine, Pancreatic cancer, CRISPR–Cas9, Genome-wide screen, Resistance

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer

    Huang, R., Langdon, S. P., Tse, M., Mullen, P., Um, I. H., Faratian, D. & Harrison, D. J., 14 Dec 2015, In : Oncotarget. 7, 4, p. 4695-4711 17 p.

    Research output: Contribution to journalArticle

  2. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models

    Ward, C., Meehan, J., Mullen, P., Supuran, C., Dixon, J. M., Thomas, J. S., Winum, J-Y., Lambin, P., Dubois, L., Pavathaneni, N-K., Jarman, E. J., Renshaw, L., Um, I. H., Kay, C., Harrison, D. J., Kunkler, I. H. & Langdon, S. P., 2015, In : Oncotarget. 6, 28, p. 24865-24870 15 p.

    Research output: Contribution to journalArticle

  3. Human tissue in systems medicine

    Caie, P. D., Schuur, K., Oniscu, A., Mullen, P., Reynolds, P. A. & Harrison, D. J., Dec 2013, In : FEBS Journal. 280, 23, p. 5949–5956

    Research output: Contribution to journalReview article

  4. Characterisation of phosphorylated checkpoint kinase 1 as a poor prognostic biomarker in serous ovarian cancer

    Francis, K. E., Mullen, P., Um, I., Kay, C., Harrison, D. J. & Langdon, S. P., Sep 2013, In : Journal of Pathology. 231, p. 46 1 p.

    Research output: Contribution to journalAbstract

  5. Computerized image analysis of tumor cell nuclear morphology can improve patient selection for clinical trials in localized clear cell renal cell carcinoma

    Um, I. H., Scott-Hayward, L., MacKenzie, M. L., Tan, P. H., Kanesvaran, R., Choudhury, Y., Caie, P. D., Tan, M-H., O'Donnell, M., Leung, S., Stewart, G. & Harrison, D. J., 6 Nov 2020, In : Journal of Pathology Informatics. 11, 8 p., 35.

    Research output: Contribution to journalArticle

Related by journal

  1. Scientific Reports (Journal)

    Matt Carter (Reviewer)

    2020

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  2. Scientific Reports (Journal)

    Manon Karin Schweinfurth (Member of editorial board)

    1 Aug 2019 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

  3. Scientific Reports (Journal)

    Alan J. Stewart (Member of editorial board)

    Jun 2019 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

  4. Scientific Reports (Journal)

    Matt Carter (Reviewer)

    2019

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  5. Scientific Reports (Journal)

    Monica Arso Civil (Reviewer)

    Jul 2018 → …

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

Related by journal

  1. A dynamic role for dopamine receptors in the control of mammalian spinal networks

    Sharples, S. A., Burma, N. E., Borowska-Fielding, J., Kwok, C. H. T., Eaton, S. E. A., Baker, G. B., Jean-Xavier, C., Zhang, Y., Trang, T. & Whelan, P. J., 2 Oct 2020, In : Scientific Reports. 10, 23 p., 16429.

    Research output: Contribution to journalArticle

  2. A highly conserved complete accessory Escherichia coli type III secretion system 2 is widespread in bloodstream isolates of the ST69 lineage

    Fox, S., Goswami, C., Holden, M., Connolly, J. P. R., Mordue, J., O’Boyle, N., Roe, A., Connor, M., Leanord, A. & Evans, T. J., 5 Mar 2020, In : Scientific Reports. 10, 11 p., 4135.

    Research output: Contribution to journalArticle

  3. A large-scale estimate on the relationship between language and motor lateralization

    Packheiser, J., Schmitz, J., Arning, L., Beste, C., Güntürkün, O. & Ocklenburg, S., 3 Aug 2020, In : Scientific Reports. 10, 10 p., 13027.

    Research output: Contribution to journalArticle

  4. A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania

    Mwamwitwa, K. W., Kaibere, R. M., Fimbo, A. M., Sabitii, W., Ntinginya, N. E., Mmbaga, B. T., Shewiyo, D. H., Shearer, M. C., Smith, A. D. & Kaale, E. A., 20 Oct 2020, In : Scientific Reports. 10, 1, 11 p., 17834.

    Research output: Contribution to journalArticle

  5. Accounting for detection unveils the intricacy of wild boar and rabbit co-occurrence patterns in a Mediterranean landscape

    Barros, A. L., Curveira-Santos, G., Marques, T. A. & Santos-Reis, M., 20 Apr 2020, In : Scientific Reports. 10, 9 p., 6651.

    Research output: Contribution to journalArticle

ID: 258893627

Top